Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update

Novocure (NASDAQ: NVCR) today reported operating statistics and preliminary, unaudited net revenues and cash balances for the fourth quarter and full year 2020. Novocure plans to discuss these results with investors at the 39^th Annual J.P. Morgan Virtual Healthcare Conference. Novocure also plans to highlight key clinical and product development programs.

Fourth quarter and full year 2020 highlights include:

Three months ended December 31,

Twelve months ended December 31,

2020

2019

% Change

2020

2019

% Change

(unaudited)

(audited)

Novocure NASDAQ:NVCR NVCR Rankings #2470 Ranked by Market Cap N/A Ranked by Dividends #122 Top Gainer NVCR Latest News Mar 2, 2026 Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer Feb 27, 2026 Novocure to Participate in 2026 Leerink Global Healthcare Conference Feb 26, 2026 Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update Feb 24, 2026 Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer (BC Cancer) Feb 11, 2026 U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer NVCR Latest SEC Filings Mar 3, 2026 [144] NovoCure Ltd SEC Filing Mar 3, 2026 [Form 4] NovoCure Ltd Insider Trading Activity Mar 3, 2026 [Form 4] NovoCure Ltd Insider Trading Activity Mar 3, 2026 [Form 4] NovoCure Ltd Insider Trading Activity Mar 3, 2026 [Form 4] NovoCure Ltd Insider Trading Activity NVCR Stock Data Market Cap 1.51B Float 100.73M Industry Medical Devices Sector Surgical & Medical Instruments & Apparatus Website Link Country Switzerland City ST. HELIER Related Articles Continue reading with these related stories $EOLS Top Gainer Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability¹ Beginning in 2026 Mar 3, 2026 +18.89% earnings $BHAT Top Loser Blue Hat Announces 1-for-50 Reverse Stock Split Mar 3, 2026 -23.47% stock split $NVCR Same Company Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer Mar 2, 2026 $NVCR Same Company Novocure to Participate in 2026 Leerink Global Healthcare Conference Feb 27, 2026 $PSTG Related Odine, a Global Technology Partner, Signs Strategic Cooperation MOU with Everpure at Mobile World Congress Mar 4, 2026 $PHG Related Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments Mar 4, 2026 $HCM Related HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors Mar 4, 2026 $HSAI Related Hesai Group to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, March 24, 2026 Mar 4, 2026 earnings date $BHLL Trending Bunker Hill Announces Effective Date of Reverse Stock Split and Update to C$30 Million LIFE Offering Mar 4, 2026 stock split $RENGF Trending Renegade Gold Engages Global One Media Mar 3, 2026 View All Latest News Explore About Editorial Policy FAQ Rhea-AI Sitemap Legal Terms of Use Cookie Notice Privacy Policy Market Data Articles Top Gainers Market Cap Momentum Scanner Stock Themes Live News Links RSS feed Facebook Reddit Add to Google News A leading AI‑powered platform for real‑time stock market news, press releases, SEC filings, earnings, and tools for trading and investing. © 2020-2026 StockTitan.net - Your Edge is Information Information only — not investment advice.